| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
2 companies
Daniels Eric Joseph serves as a Chief Development Officer at KPRX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $115K at current prices.
The biggest single holding is KPRX (~$62K) as Chief Development Officer. Net of sales, the recent Form 4 record there shows accumulation of 1,431 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14, 2024 | KPRX Kiora Pharmaceuticals Inc | Chief Development Officer | Buy | 1,431 | $5.29 | $7,569.99 | +14.6% | -32.5% | -43.7% |